Amino Acids and Immune Response: A Role for Cysteine, Glutamine, Phenylalanine, Tryptophan and Arginine in T-cell Function and Cancer?

Pathology and Oncology Research

Volumn 21, Issue 1, 2015, Pages 9-17

  Sikalidis, Angelos K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Amino acids; Arginine; Avidity; Cysteine; Glutamine; Immune response; Immunomodulation; Phenylalanine; Signaling; T cell; Tryptophan

Indexed keywords

ARGININE; BRANCHED CHAIN AMINO ACID; CD3 ANTIGEN; CD69 ANTIGEN; CYSTEINE; GAMMA INTERFERON; GLUTAMINE; GLUTATHIONE; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; METHIONINE; PHENYLALANINE; PHOSPHOLIPASE C; REACTIVE OXYGEN METABOLITE; T LYMPHOCYTE RECEPTOR; TAURINE; THIOREDOXIN; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE; TUMOR NECROSIS FACTOR ALPHA; AMINO ACID;

ADAPTIVE IMMUNITY; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BINDING AFFINITY; BIOAVAILABILITY; BONE MARROW CELL; CALCIUM TRANSPORT; CANCER IMMUNOLOGY; CANCER PROGNOSIS; CANCER RISK; CARDIA CARCINOMA; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DETOXIFICATION; DIET SUPPLEMENTATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXPERIMENTAL COLITIS; GLUTATHIONE METABOLISM; HELPER CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER T CELL; NEOPLASM; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRINITROBENZENE SULFONIC ACID INDUCED COLITIS; TUMOR CELL DESTRUCTION; TUMOR MICROENVIRONMENT; ANIMAL; CELL PROLIFERATION; IMMUNOLOGY; PHYSIOLOGY;

AMINO ACIDS; ANIMALS; CELL PROLIFERATION; HUMANS; IMMUNOMODULATION; NEOPLASMS; T-LYMPHOCYTES;

EID: 84920822820     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-014-9860-0     Document Type: Review

References (76)

1. Steinke JW, Lawrence MG (2014) T-cell biology in immunotherapy. Ann Allergy Asthma Immunol 112:195–199
2. Smith KA (2014) Revisiting the first long-term culture of antigen-specific cytotoxic T cells. Front Immunol 5:194
3. Viret C, Janeway CA Jr (1999) MHC and T cell development. Rev Immunogenet 1:91–104
4. von Essen MR, Kongsbak M, Geisler C (2012) Mechanisms behind functional avidity maturation in T cells. Clin Dev Immunol 2012:163453
5. + human T lymphocyte subsets. Eur J Immunol 23(1):61–68
6. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Ødum N, Geisler C (2010) Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 11(4):344–349
7. Ericsson PO, Orchansky PL, Carlow DA, Teh HS (1996) Differential activation of phospholipase C-γ1 and mitogen-activated protein kinase in naïve and antigen-primed CD4 T cells by the peptide/MHC ligand. J Immunol 156(6):2045–2053
8. Viganò S, Utzschneider DT, Perreau M, Pantaleo G, Zehn D, Harari A (2012) Functional avidity: a measure to predict the efficacy of effector T cells? Clin Dev Immunol 153863
9. Ebert PJ, Jiang S, Xie J, Li QJ, Davis MM (2009) An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat Immunol 10(11):1162–1169
10. Garcia Z, Pradelli E, Celli S, Beuneu H, Simon A, Bousso P (2007) Competition for antigen determines the stability of T cell-dentritic cell interactions during clonal expansion. Proc Natl Acad Sci U S A 104(11):4553–4558
11. McMahan RH, Slansky JE (2007) mobilizing the low-avidity T cell repertoire to kill tumors. Semin Cancer Biol 17(4):317–329
12. Choi EML, Chen JL, Wooldridge et al (2003) High avidity antigen-specific CTL identified by CD8-idependent tetramer staining. J Immunol 171(10):5116–5123
13. Xiao Z, Mescher MF, Jameson SC (2007) Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation. J Exp Med 294(11):2667–2677
14. + T cells without selection of higher affinity TCR. Nat Immunol 2(8):711–717
15. Rechtsteiner G, Warger T, Hofmann M, Rammensee HG, Schild HJ, Radsak MP (2006) Precursor frequency can compensate for lower TCR expression in T cell competition during priming in vivo. Eur J Immunol 36(10):2613–2623
16. Sikalidis AK, Lee J-I, Stipanuk MH (2011) Cellular responses to indispensable amino acid deficiency are mediated through the integrated stress response pathway. Amino Acids 41(1):159–171
17. Sikalidis AK, Stipanuk MH (2010) Growing rats respond to a sulfur amino acid-deficient diet by phosphorylation of eIF2α and induction of adaptive components of the integrated stress. J Nutr 140(6):1080–1085
18. Bella DL, Hirschberger LL, Hosokawa Y, Stipanuk MH (1999) The mechanisms involved in the regulation of key enzymes of cysteine metabolism in rat liver in vivo. Am J Physiol 276 (Endocrin. Metab. 39): E326–E335
19. Bella DL, Hahn C, Stipanuk MH (1999) The effects of non-sulfur amino acids and of sulfur amino acids on the regulation of hepatic enzymes of cysteine metabolism. Am J Phsyiol 277(Endocrin. Metab. 40): E144-E153
20. Cresenzi CL, Lee JI, Stipanuk MH (2003) Cysteine is the metabolic signal responsible for dietary regulation of hepatic cysteine dioxygenase and glutamate cysteine ligase in intact rats. J Nutr 133(9):2697–2702
21. Yang BH, Wang X, Ren X (2012) Amino acid metabolism related to immune tolerance by MDSCs. Int Rev Immunol 31(3):177–183
22. Rodríguez PC, Ochoa AC (2006) T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress. Semin Cancer Biol 16(1):66–72
23. + T cells express transporters for both cysteine and cystine. Sci Rep 2:266
24. Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S (2010) Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 70(1):68–77
25. Yan Z, Banerjee R (2010) Redox remodeling as an immunoregulatory strategy. Biochemistry 49(6):1059–1066
26. Sido B, Lasitschka F, Giese T, Gassler N, Funke B, Schröder-Braunstein J, Brunnemer U, Meuer SC, Autschbach F (2008) A prominent role for mucosal cystine/cysteine metabolism in intestinal immunoregulation. Gastroenterology 134(1):179–191
27. Yan Z, Garg SK, Banerjee R (2010) Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells. J Biol Chem 285(53):41525–41532
28. Edinger AL, Thompson CB (2002) Antigen-presenting cells control T cell proliferation by regulating amino acid availability. Proc Natl Acad Sci U S A 99(3):1107–1109
29. Dröge W, Eck HP, Gmünder H, Mihm S (1991) Dysregulation of plasma amino acid levels in HIV-infection and cancer and its relevance for the immune system. Amino Acids 1(2):193–198
30. Mihm S, Galter D, Droge W (1995) Modulation of transcription factor NF kappa B activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J 9(2):246–252
31. Dröge W, Eck HP, Gmunder H, Mihm S (1991) Modulation of lymphocyte functions and immune response by cysteine and cysteine derivatives. Am J Med 91(3C):140S–144S
32. Grimble RF (2006) The effects of sulfur amino acid intake on immune function in humans. J Nutr 136(6 Suppl):1660S–1665S
33. Murphy G, Fan JH, Mark SD, Dawsey SM, Selhub J, Wang J, Taylor PR, Qiao YL, Abnet CC (2011) Prospective study of serum cysteine levels and oesophageal and gastric cancers in China. Gut 60(5):618–623
34. Gostner JM, Becker K, Fuchs D, Sucher R (2013) Redox regulation of the immune response. Redox Rep 18(3):88–94
35. Yan Z, Garg SK, Kipnis J, Banerjee R (2009) Extracellular redox modulation by regulatory T cells. Nat Chem Biol 5(10):721–723
36. Matsue H, Edelbaum D, Shalhevet D, Mizumoto N, Yang C, Mummert ME et al (2003) Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol 171(6):3010–3018
37. Los M, Schenk H, Hexel K, Baeuerle PA, Dröge W, Schulze-Osthoff K (1995) IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J 14(15):3731–3740
38. Miller TW, Wang EA, Gould S, Stein EV, Kaur S, Lim L, Amarnath S, Fowler DH, Roberts DD (2012) Hydrogen sulfide is an endogenous potentiator of T cell activation. J Biol Chem 287(6):4211–4221
39. Kontny E, Szczepanska K, Kowalczewski J, Kurowska M, Janicka I, Marcinklewicz J, Maslinski W (2000) The mechanism of taurine chloramine inhibition of cytokine IL-6, IL-8 production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 43(10):2169–2177
40. Grimble RF (1994) Sulphur amino acids and the metabolic response to cytokines. Adv Exp Med Biol 359:41–49
41. Huxtable RJ (1996) Taurine past, present and future. Adv Exp Med Biol 403:641–650
42. Grimble RF (1996) Theory and efficacy of antioxidant therapy. Curr Opin Crit Care 2:260–266
43. Chorazy M, Kontny E, Marcinklewicz J, Maslinski W (2002) Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells. Amino Acids 23(4):407–413
44. Winder B, Lebilhuber F, Frick B, Laich A, Artner-Dworzak E, Fuchs D (2002) Moderate hyperchromocysteinaemia ad immune activation in Parkinson’s disease. J Neural Transm 109(12):1445–1452
45. Gottfried E, Kreutz M, Mackensen A (2012) Tumor metabolism as modulator of immune response and tumor progression. Semin Cancer Biol 22:335–341
46. Newsholme P (2001) Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr 131(9 Suppl):2512–2522
47. Wilmore DW, Shabert JK (1998) The role of glutamine in immunologic responses. Nutrition 14(4):618–626
48. Hammami I, Chen J, Bronte V, DeCrescenzo G, Jolicoeur M (2012) L-glutamine is a key parameter in the immunosuppression phenomenon. Biochem Biophys Res Commun 425(4):724–729
49. Raber P, Ochoa AC, Paulo C (2012) Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives. Immunol Investig 41(6–7):614–634
50. Barbul A (1990) Arginine and immune function. Nutrition 6(6–7):53–58
51. Taheri F, Ochoa JB, Faghiri Z, Culotta K, Park HJ, Lan MS et al (2001) L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin Cancer Res 7(3 Suppl):958s–965s
52. Rodrigez PC, Zen AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC (2002) Regulation of T cell receptor CD3 zeta chain expression by L-arginine. J Biol Chem 277(24):21123–21129
53. Albina JE, Caldwell MD, Henry WL Jr, Mills CD (1989) Regulation of macrophage functions by L-arginine. J Exp Med 169(3):1021–1029
54. Popovic PJ, Zeh HJ 3rd, Ochoa JB (2007) Arginine and immunity. J Nutr 137(6 Suppl 2):1681S–1686S
55. DeSanctis F, Sandri S, Ferrarini G, Pagliarello I, Sartoris S, Ugel S, Marigo I, Molon B, Bronte V (2014) The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironment. Front Immunol 5:1–16
56. Terabe M, Swann J, Ambrosino E et al (2005) A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cells is sufficient for down-regulation of tumor immunosurveillance. J Exp Med 202(12):1627–1633
57. −) T cells by hudrogen peroxide-induced oxidative stress. J Immunol (Baltimore) 174(10):6080–6087
58. Schroder AJ, Pavlidis P, Arimura A, Capece D, Rothman PB (2002) Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes. J Immunol 168(3):996–1000
59. Godin-Ethier J, Hanafi LA, Piccirillo CA, Lapointe R (2011) Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives. Clin Cancer Res 17(22):6985–6991
60. Mellor AL, Munn DH (2001) Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J Reprod Immunol 52(1–2):5–13
61. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189(9):1363–1372
62. Lee GK, Park HJ, Macleod M, Chandler P, Munn DH, Mellor AL (2002) Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107(4):452–460
63. Weinlich G, Murr C, Richardsen L, Winkler C, Fuchs D (2007) Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients. Dermatology 214(1):8–14
64. Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Göbel G, Margreiter R, Königsrainer A, Fuchs D, Amberger A (2006) Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 12(4):1144–1151
65. Ramanathan A, Wang C, Schreiber SL (2005) Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci U S A 102(17):5992–5997
66. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR et al (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64(11):3892–3899
67. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, Lehmann I, von Deimling A, Wick W, Platten M (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478(7368):197–203
68. Pilotte L, Larrieu P, Stroobant V, Colau D, Dolusic E, Frédérick R, De Plaen E, Uyttenhove C, Wouters J, Masereel B, Van den Eynde BJ (2012) Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci U S A 109(7):2497–2502
69. Platten M, Wick W, Van den Eynde BJ (2012) Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res 72(21):5435–5440
70. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillence to tumor escape. Nat Immunol 3(11):991–998
71. Mizoguchi H, O’Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC (1992) Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258(5089):1795–1798
72. Lee J-I, Dominy JE Jr, Sikalidis AK, Hirschberger LL, Wang W, Stipanuk MH (2008) HepG2/C3A cells respond to cysteine-deprivation by induction of the amino acid deprivation/integrated stress response pathway. Physiol Genomics 33(2):218–229
73. Sikalidis AK, Mazor KM, Kang M, Liu H, Stipanuk MH (2013) Total 4EBP1 is elevated in liver of rats in response to low sulfur amino acid intake. J Amino Acids 2013:864757
74. Sikalidis AK (2013) Cellular and animal indispensable amino acid limitation responses and health promotion. Can the two be linked? A critical review. Int J Food Sci Nutr 64(3):300–311
75. Maciolek JA, Pasternak JA, Wilson HL (2014) Metabolism of activated T lymphocytes. Curr Opin Immunol 27:60–74
76. Baracos VE, Mackenzie ML (2006) Investigations of branched-chain amino acids and their metabolites in animal models of cancer. J Nutr 136(1 Suppl):237S–242S